Pharmamotion

Drug therapy for heart failure: PowerPoint presentations (2)

11/12/09 •

Both lectures provide an introduction on clinical features of the disease and its physiopathology, later they review the most relevant pharmacological properties of each drug class.

Pharmacotherapy updates for your medical education (4)

1/08/10 •

Pharmacotherapy news and updates from medical journals and blogs.

Drugs for CINV prophylaxis and treatment (0)

12/22/09 •

This article overviews the pharmacology of drugs used for the prevention and treatment of chemotherapy induced nausea and vomiting (CINV). A brief introduction on the pathophysiology is presented, to be followed by a discusssion on the different drug classes.

Clinical guidelines on CINV management (1)

12/22/09 •

These are the latest guidelines on antiemetic managagement of chemotherapy-induced nausea and vomiting published on The Oncologist. Below that, an article from Supportive Oncology discusses the most relevant changes made in the 2006 update.

Hypertension management: pharmacotherapy lecture notes (PDF) (0)

12/19/09 •

Phharmacological management of hypertension: by the Pharmacology OpenCourseWare initiative at Harvard Medical School – MIT.

PowerPoint: overview of cephalosporins pharmacology (0)

12/17/09 •

This presentation is focused on the core characteristics of cephalosporins as a group. It highlights the differences in terms of bacterial coverage between different generations, using some clinical uses as examples.
PowerPoint: cephalosporins pharmacology

Download PPT
Lecture outline:

Chemical characteristics of beta-lactams.
Mechanism of action.
First, second, third and fourth  generation cephalosporins drug list.
Bacterial coverage of first, second, third and fourth [...]

PPI – Clopidogrel (Plavix) interaction: the latest news (1)

12/14/09 •

This page will be constantly updated on the latest news about the possible interaction between the antiplatelet drug clopidogrel (Plavix) and PPIs.

Animation: NRTIs mechanism of action (4)

12/13/09 •

Nucleoside analog reverse transcriptase inhibitors (NRTIs) are nucleoside analogues that act as competitive inhibitors of HIV-1 reverse transcriptase. As shown in the animation, these drugs compete with nucleoside triphosphates for access to reverse transcriptase.
All NRTIs lack a 3-hydroxyl group; thus, their incorporation into a growing DNA chain results in its termination. They require intracytoplasmic activation [...]

Calcium channel blockers: classification, mechanism of action and indications (4)

12/12/09 •

Overview on calcium channel blockers, in this first part we will discuss their classification, mechanism of action as well as clinical indications.